Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Diabetes Mellitus, Type 2"
topic_facet:"Recruitment Status: Active, not recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (333)
1
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes : Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Small Bowel Diversion : Jejuno-ileal and Jejuno-colic Bypass as a New Bariatric Method in Treatment Diabetes and Obesity
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight : Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity and Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus : Performance of NT-proBNP in Risk Stratification for Cardiovascular Events and Mortality in Patients With Diabetes (PISCES)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program : A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery : Clinical Effectiveness of Continuous Blood Glucose Monitoring In Patients With Type 2 Diabetes Undergoing Orthopaedic Hip or Knee Replacement Surgery
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes : A Phase 1, Open-Label, Multiple-Dose Study to Investigate Steady-State Pharmacokinetics and Pharmacodynamics During a Euglycemic Clamp of LY3209590 in Participants With Type 2 Diabetes Mellitus
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin : A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) : A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) : A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 Administered Weekly Using a Fixed Dose Escalation Compared to Insulin Glargine in Insulin-Naïve Adults With Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Diabetes Mellitus, Type 2
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Medienart
333
Aufsätze
333
E-Artikel
333
E-Ressourcen
Zeitschriftentitel
333
ClinicalTrials.gov
Thema
333
610
Diabetes Mellitus, Type 2
Recruitment Status: Active, not recruiting
266
Study Type: Interventional
239
Diabetes Mellitus
67
Study Type: Observational
45
Phase: Phase 3
28
Phase: Phase 4
20
Obesity
19
Kidney Diseases
17
Phase: Phase 2
16
Medical Condition: Diabetes Mellitus, Type 2
15
Diabetes Mellitus, Type 1
15
Overweight
15
Renal Insufficiency, Chronic
13
Cardiovascular Diseases
11
Prediabetic State
10
Coronary Artery Disease
10
Insulin Resistance
8
Hyperglycemia
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
321
2020-
12
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
333
Englisch
Haven't found what you're looking for?
Wird geladen...